Ranges for key inputs in spectrum
| Input | Mean | Range |
|---|---|---|
| Median time in years from infection to AIDS death for males | 8.6 | 7.4–9.8 |
| Median time in years from infection to AIDS death for females | 9.4 | 8.2–10.6 |
| Cumulative mortality in HIV+ children | ||
| 2 years | 0.48 | 0.30–0.55 |
| 5 years | 0.60 | 0.41–0.55 |
| 10 years | 0.82 | 0.62–1.00 |
| 15 years | 1.00 | 0.74–1.00 |
| Ratio of prevalence for 15–19 to 25–29 for males | 0.19 | 0.05–0.31 |
| Ratio of prevalence for 20–24 to 25–29 for males | 0.30 | 0.05–0.62 |
| Ratio of prevalence for 15–19 to 25–29 for females | 0.22 | 0.01–0.36 |
| Ratio of prevalence for 20–24 to 25–29 for females | 0.63 | 0.53–0.72 |
| Mean | Standard deviation | |
| Mother to child transmission rate with no prophylaxis | 0.35 | 0.05 |
| Mother to child transmission rate with prophylaxis | 0.28 | 0.05 |
| Ratio of fertility of HIV+ to HIV− women aged 15–19 | 1.5 | 0.20 |
| Ratio of fertility of HIV+ to HIV− women aged 20–49 | 0.70 | 0.10 |
| Percent of adults on ART surviving to the next year | 0.90 | 0.05 |
| Percent of children on cotrimoxazole surviving to the next year | 0.91 | 0.05 |
| Percent of children on antiretroviral treatment surviving to the next year | 0.90 | 0.05 |